<qa>  What is the name of the study that was randomized, double-blind, placebo controlledCICL670A2209E1: A one-year open-label extension to a randomized, double-blind, placebo-controlled, phase II study to evaluate efficacy and safety of deferasirox in non-transfusion dependent thalassemia patients with iron overload Thalassa. 